{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T02:34:29Z","timestamp":1695609269693},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11940-001-0014-9","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T18:14:20Z","timestamp":1180980860000},"page":"519-525","source":"Crossref","is-referenced-by-count":1,"title":["Paroxysmal dyskinesia"],"prefix":"10.1007","volume":"3","author":[{"given":"Paul S.","family":"Fishman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ana.410380405","volume":"38","author":"M Demirkiran","year":"1995","unstructured":"Demirkiran M, Jankovic J: Paroxymal dyskinesias: clinical features and classification. Ann Neurol 1995, 38:571\u2013579.","journal-title":"Ann Neurol"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.55.2.169","volume":"55","author":"SF Berkovic","year":"2000","unstructured":"Berkovic SF: Paroxysmal movement disorders and epilepsy. Links across the channel. Neurology 2000, 55:169\u2013170. A concise review of the possible biologic relationship between both disorders.","journal-title":"Neurology"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9","volume":"45","author":"R Guerrini","year":"1999","unstructured":"Guerrini R, Bonanni P, Nardocci N, et al.: Autosoma recessive rolandic epilepsy with paroxysmal exerci induced dystonia and writer\u2019s cramp: deliniation of the syndr and gene mapping to chromosome 16p12-11.2. Ann Neurol 1999, 45:344\u2013352.","journal-title":"Ann Neurol"},{"key":"14_CR4","first-page":"310","volume-title":"Movement Disorders","author":"S Fahn","year":"1994","unstructured":"Fahn S: The paroxysmal dyskinesias. In Movement Disorders, vol 3. Edited by Marsden CD, Fahn S. Oxford: Butterworth-Henemann Ltd.; 1994:310\u2013345."},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004150050325","volume":"246","author":"KP Bhatia","year":"1999","unstructured":"Bhatia KP: The paroxysmal dyskinesias. J Neurol 1999, 246:149\u2013155.","journal-title":"J Neurol"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/brain\/123.10.2040","volume":"123","author":"EM Valente","year":"2000","unstructured":"Valente EM, Spacey SD, Wali GM, et al.: A second paroxysmal kinesigenic choreathetosis locus (EKD2) mapping on 16q13-q22. 1 indicates a family of genes, which give rise to paroxysmal disorders on human chromosome 16. Brain 2000, 123:2040\u20132045.","journal-title":"Brain"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.55.2.224","volume":"55","author":"KJ Swoboda","year":"2000","unstructured":"Swoboda KJ, Soong B-W, McKenna C, et al.: Paroxysmal kinesigenic dyskinesia and infantile convulsions. Neurology 2000, 55:224\u2013230. This genetic study gives a solid foundation to a united view of paroxysmal dyskinesia and forms of epilepsy.","journal-title":"Neurology"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00155-8","volume":"43","author":"S Arroyo","year":"2001","unstructured":"Arroyo S, Santamaria J, Setoain JF, et al.: Nocturnal paroxysmal dystonia related to a prerolandic dysplasia. Epilepsy Res 2001, 43:1\u20139.","journal-title":"Epilepsy Res"},{"key":"14_CR9","volume-title":"Paroxysmal Dystonias and Dyskinesias Netowrk: Summary of Findings from Member Survey","author":"T Sobel","year":"2001","unstructured":"Sobel T: Paroxysmal Dystonias and Dyskinesias Netowrk: Summary of Findings from Member Survey. Chicago: Dystonia Medical Research Foundation; 2001. Although uncontrolled, the first published patient survey on the topic."},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.70.2.247","volume":"70","author":"B Meyer","year":"2001","unstructured":"Meyer B, Irlbacher K, Meierkord H: Analysis of stimuli triggering attacks of paroxysmal dystonia induced by exertion. J Neurol Neurosurg Psychiatry 2001, 70:247\u2013251. A rare and insightful evaluation of human physiology.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s004150050318","volume":"246","author":"MK Houser","year":"1999","unstructured":"Houser MK, Soland VL, Bhatia KP, et al.: Paroxysmal kinesigenic choreoathetosis: a report of 26 patients. J Neurol 1999, 246:120\u2013126.","journal-title":"J Neurol"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1212\/WNL.52.1.109","volume":"52","author":"SM Mirsattari","year":"1999","unstructured":"Mirsattari SM, Berry ME, Holden JK, et al.: Paroxysmal dyskinesias in patients with HIV infection. Neurology 1999, 52:109\u2013114.","journal-title":"Neurology"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.47.4.1104-a","volume":"47","author":"T Wein","year":"1996","unstructured":"Wein T, Andermann F, Silver K, et al.: Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine. Neurology 1996, 47:1104\u20131106.","journal-title":"Neurology"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1034\/j.1600-0404.2000.9l3331.x","volume":"101","author":"A Gokcay","year":"2000","unstructured":"Gokcay A, Gokcay F: Oxcarbazepine therapy in paroxysmal kinisigenic choreoathetosis. Acta Neuro Scan 2000, 101:344\u2013345.","journal-title":"Acta Neuro Scan"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1017\/S0012162200001286","volume":"42","author":"MA Uberall","year":"2000","unstructured":"Uberall MA, Wenzel D: Effectiveness of lamotrigine in children with paroxysmal kinesogenic choreoathetosis. Dev Med Child Neurol 2000, 42:699\u2013700.","journal-title":"Dev Med Child Neurol"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp.68.6.796a","volume":"68","author":"AC Pereira","year":"2000","unstructured":"Pereira AC, Loo WJ, Bamford M, Wroe SJ: Use of lamotrigine to treat paroxysmal kinesigenic choreoathetosis. J Neurol Neurosurg Psychiatry 2000, 68:796\u2013797.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410020405","volume":"2","author":"JW Lance","year":"1977","unstructured":"Lance JW: Familial paroxysmal dystonic choreoathetosis and its difference from related syndromes. Ann Neurol 1977, 2:285\u2013293.","journal-title":"Ann Neurol"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/1531-8257(200007)15:4<648::AID-MDS1008>3.0.CO;2-T","volume":"15","author":"PR Jarman","year":"2000","unstructured":"Jarman PR, Bhatia KP, Davie C, et al.: Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family. Mov Disord 2000, 15:648\u2013657.","journal-title":"Mov Disord"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archneur.1980.00500540103027","volume":"37","author":"DL Coulter","year":"1980","unstructured":"Coulter DL, Donofrio P: Haloperidol for nonkinesiongenic paroxysmal dyskinesia. Arch Neurol 1980, 37:325\u2013326.","journal-title":"Arch Neurol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00313627","volume":"230","author":"H Przuntek","year":"1983","unstructured":"Przuntek H, Monninger P: Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type. J Neurol 1983, 230:163\u2013169.","journal-title":"J Neurol"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.870130346","volume":"13","author":"I Maurer","year":"1998","unstructured":"Maurer I, Grunwal T, Elger CE: Clozapine treatment of delayed-onset paroxysmal hemidystonia. Mov Disord 1998, 13:614\u2013616.","journal-title":"Mov Disord"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.49.5.1441","volume":"49","author":"RS Chudnow","year":"1997","unstructured":"Chudnow RS, Mibela RA, Owen DB, Roach ES: Gabapentin for familial paroxysmal dystonic choreoathetosis. Neurology 1997, 49:1441\u20131442.","journal-title":"Neurology"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ana.410130415","volume":"13","author":"R Kurlan","year":"1983","unstructured":"Kurlan R, Shoulson I: Familial paroxysmal dystonic choreoathetosis and response to alternate-day oxazepam therapy. Ann Neurol 1983, 13:456\u2013457.","journal-title":"Ann Neurol"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archneur.56.6.721","volume":"56","author":"H Matsuo","year":"1999","unstructured":"Matsuo H, Kamakura K, Saito M, et al.: Familial paroxysmal dystonic choreoathetosis: clinical findings in a large Japanese family and genetic linkage to 2q. Arch Neurol 1999, 56:721\u2013726.","journal-title":"Arch Neurol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0306-4522(00)00073-7","volume":"97","author":"JH Rehders","year":"2000","unstructured":"Rehders JH, Loscher W, Richter A: Evidence for striatal dopamingeric overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model. Neuroscience 2000, 97:267\u201377. A representative example of the power of this animal model to both examine physiology and assess possible therapies.","journal-title":"Neuroscience"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-2999(00)00627-0","volume":"404","author":"A Richter","year":"2000","unstructured":"Richter A, Hamann M, Bartling C: CGS 21680 exerts marked antidystonic effects in a genetic model of paroxysmal dyskinesia. Eur J Pharmacol 2000, 404:299\u2013302.","journal-title":"Eur J Pharmacol"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(00)00105-9","volume":"391","author":"W Loscher","year":"2000","unstructured":"Loscher W, Richter A: Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia. Eur J Pharmacol 2000, 391:251\u2013254.","journal-title":"Eur J Pharmacol"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-2999(99)00104-1","volume":"369","author":"A Richter","year":"1999","unstructured":"Richter A, Loscher W: Gabapentin decreases the severity of dystonia at low doses in genetic animal model of paroxysmal dystonic choreoathetosis. Eur J Pharmocol 1999, 369:335\u2013338.","journal-title":"Eur J Pharmocol"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp.47.3.275","volume":"47","author":"GT Plant","year":"1984","unstructured":"Plant GT, Williams AC, Earl CJ, Marsden CD: Familial paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry 1984, 47:275\u2013279.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.57.4.570","volume":"57","author":"E Palomeras","year":"2000","unstructured":"Palomeras E, Sanz P, Cano A, Fossas P: Dystonia in a patient treated with propranolol and gabapentin. Arch Neurol 2000, 57:570\u2013571.","journal-title":"Arch Neurol"},{"key":"14_CR31","first-page":"403","volume":"50","author":"SB Bressman","year":"1988","unstructured":"Bressman SB, Fahn S, Burke RE: Paroxysmal nonkinesigenic dystonia. Adv Neurol 1988, 50:403\u2013413.","journal-title":"Adv Neurol"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00007611-199902000-00014","volume":"2","author":"WL Olson","year":"1999","unstructured":"Olson WL: Acetazolamide relieves concurrent episodic movement disorder encountered in Southern states. South Med J 1999, 2:228\u2013232.","journal-title":"South Med J"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/WNL.42.4.919","volume":"42","author":"KD Sethi","year":"1992","unstructured":"Sethi KD, Hess DC, Huffnagle VH, Adams RJ: Acetazolamide treatment of paroxysmal dystonia in central demyelinating disease. Neurology 1992, 42:919\u2013921.","journal-title":"Neurology"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1468-1331.2000.00049.x","volume":"7","author":"J Guimaraes","year":"2000","unstructured":"Guimaraes J, Vale Santos J: Paroxysmal dystonia induced by exercise and acetazolamide. Eur J Neurol 2000, 7:237\u2013240.","journal-title":"Eur J Neurol"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.49.1.177","volume":"49","author":"JK Fink","year":"1997","unstructured":"Fink JK, Hedera P, Mathay JG, Albin RL: Paroxysmal dystonic choreoathetosis linked to chromosome 2 clinical analysis and proposed pathophysiology. Neurology 1997, 49:177\u2013183.","journal-title":"Neurology"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.65.4.604a","volume":"65","author":"KP Bhatia","year":"1998","unstructured":"Bhatia KP, Marsden CD, Thomas DG: Posteroventral pallidotomy can ameliorate attacks of paroxysmal dystonia induced by exercise. J Neurol Neurosurg Psychiatry 1998, 65:604\u2013605.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1212\/WNL.56.2.268","volume":"56","author":"TJ Loher","year":"2001","unstructured":"Loher TJ, Krauss JK, Burgunder J-M, et al.: Chronic thalamic stimulation for treatment of paroxysmal nonkinesigenic dyskinesia. Neurology 2001, 56:268\u2013270.","journal-title":"Neurology"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-001-0014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-001-0014-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-001-0014-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:44Z","timestamp":1559437004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-001-0014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11940-001-0014-9","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}